Harold Marcotte is a Senior Researcher at the Division of Clinical Immunology, Department of Laboratory Medicine at Karolinska Institutet, Stockholm, Sweden. He obtained a B.S. degree (1990) in microbiology at the Université Laval, Quebec City, QC, Canada, where he also did his M.S. (1992) and Ph.D. (1997) degrees under the supervision of Dr. Marc Lavoie, studying interactions between secretory IgA and indigenous microbiota. His postdoctorals studies were performed with Dr. Jerry Wells at the Department of Pathology, University of Cambridge, Cambridge, UK (1997–1998) and with Professor Gianni Pozzi at the Department of Molecular Biology, University of Siena, Siena, Italy (1998–2000) where he studied the use of engineered lactic acid bacteria for delivery of vaccines. In 2000, he joined the laboratory of Prof. Lennart Hammarström at the Division of Clinical Immunology at Karolinska Institutet working on delivery of antibody fragments by lactobacilli for treatment of mucosal infections. His current research focuses on delivery of therapeutics molecules by lactic acid bacteria, expression system, probiotics and immunotherapy against mucosal pathogens.
Biography Updated on 2 January 2011